Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 07, 2022
How exactly should China's policymakers wade through competing models and guidance as it looks to ease its anti-COVID measures? This blog looks at how they should use models, using the case of the state of Hawaii; in sum, recommending that China’s National Health Commission take a thoughtful approac...
Blog Post
November 17, 2022
How does public health surveillance work, and how can it be done better? Amanda Glassman tackles these questions with Dr. Oliver Morgan of the WHO and Dr. Theo Vos of the Institute for Health Metrics and Evaluation. Together, they examine the successes and limitations of public health surveillance d...
Blog Post
November 07, 2022
What’s the latest in international economic development research? Last weekend was the North East Universities Development Consortium annual conference, often called NEUDC. With more than 135 papers presented (and almost all of them available for download), it’s a great way to see recent trends in t...